Massachusetts Financial Services’s Parabilis Medicines PBLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8M Buy
365,415
+69,453
+23% +$2.42M ﹤0.01% 727
2026
Q2
$8.1M Buy
+295,962
New +$8.18M ﹤0.01% 774

Other funds holding PBLS

Massachusetts Financial Services's PBLS Position: Q3 2026 in Review

Massachusetts Financial Services increased its Parabilis Medicines (PBLS) stake by 23% in Q3 2026, buying an estimated $2.42M and bringing the position to 365,415 shares worth $11.8M. The position accounts for ﹤0.01% of the portfolio, ranked #727.

Massachusetts Financial Services first reported a position in PBLS in Q2 2026 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.

  • Massachusetts Financial Services held 365,415 shares of Parabilis Medicines worth $11.8M as of Q3 2026.
  • Massachusetts Financial Services bought 69,453 Parabilis Medicines shares in Q3 2026, an estimated $2.42M.
  • Parabilis Medicines made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q3 2026, its #727 holding.
  • Massachusetts Financial Services first reported a position in Parabilis Medicines in Q2 2026 and has held it in 2 quarters since.
  • 127 funds tracked by Wall St. Rank held Parabilis Medicines as of Q3 2026.

Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.